Cargando…
Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908322/ https://www.ncbi.nlm.nih.gov/pubmed/29683132 http://dx.doi.org/10.18632/oncotarget.25064 |
_version_ | 1783315701865381888 |
---|---|
author | Gritt, Giuseppe Gianatt, Andrea Petronzeii, Fiorella De Santis, Rita Pavoni, Chiara Rossi, Riccardo Lorenzo Cattaneo, Laura Spagnoli, Luigi Giusto Ferrar, Silvia Ross, Andrea Barbu, Anna Maria Rambald, Alessandro |
author_facet | Gritt, Giuseppe Gianatt, Andrea Petronzeii, Fiorella De Santis, Rita Pavoni, Chiara Rossi, Riccardo Lorenzo Cattaneo, Laura Spagnoli, Luigi Giusto Ferrar, Silvia Ross, Andrea Barbu, Anna Maria Rambald, Alessandro |
author_sort | Gritt, Giuseppe |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5908322 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-59083222018-04-20 Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy Gritt, Giuseppe Gianatt, Andrea Petronzeii, Fiorella De Santis, Rita Pavoni, Chiara Rossi, Riccardo Lorenzo Cattaneo, Laura Spagnoli, Luigi Giusto Ferrar, Silvia Ross, Andrea Barbu, Anna Maria Rambald, Alessandro Oncotarget Correction Impact Journals LLC 2018-03-30 /pmc/articles/PMC5908322/ /pubmed/29683132 http://dx.doi.org/10.18632/oncotarget.25064 Text en Copyright: © 2018 Gritti et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Correction Gritt, Giuseppe Gianatt, Andrea Petronzeii, Fiorella De Santis, Rita Pavoni, Chiara Rossi, Riccardo Lorenzo Cattaneo, Laura Spagnoli, Luigi Giusto Ferrar, Silvia Ross, Andrea Barbu, Anna Maria Rambald, Alessandro Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy |
title | Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy |
title_full | Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy |
title_fullStr | Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy |
title_full_unstemmed | Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy |
title_short | Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy |
title_sort | correction: evaluation of tenascin-c by tenatumomab in t-cell non-hodgkin lymphomas identifies a new target for radioimmunotherapy |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908322/ https://www.ncbi.nlm.nih.gov/pubmed/29683132 http://dx.doi.org/10.18632/oncotarget.25064 |
work_keys_str_mv | AT grittgiuseppe correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy AT gianattandrea correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy AT petronzeiifiorella correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy AT desantisrita correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy AT pavonichiara correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy AT rossiriccardolorenzo correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy AT cattaneolaura correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy AT spagnoliluigigiusto correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy AT ferrarsilvia correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy AT rossandrea correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy AT barbuannamaria correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy AT rambaldalessandro correctionevaluationoftenascincbytenatumomabintcellnonhodgkinlymphomasidentifiesanewtargetforradioimmunotherapy |